These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36562098)

  • 21. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    Oster ME; Shay DK; Su JR; Gee J; Creech CB; Broder KR; Edwards K; Soslow JH; Dendy JM; Schlaudecker E; Lang SM; Barnett ED; Ruberg FL; Smith MJ; Campbell MJ; Lopes RD; Sperling LS; Baumblatt JA; Thompson DL; Marquez PL; Strid P; Woo J; Pugsley R; Reagan-Steiner S; DeStefano F; Shimabukuro TT
    JAMA; 2022 Jan; 327(4):331-340. PubMed ID: 35076665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
    Bouattour N; Hdiji O; Sakka S; Fakhfakh E; Moalla K; Daoud S; Farhat N; Damak M; Mhiri C
    Neurol Sci; 2022 Feb; 43(2):755-761. PubMed ID: 34796417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review.
    N AM; Saleh AM; Khalid A; Alshaya AK; Alanazi SMM
    Clin Rheumatol; 2022 May; 41(5):1577-1582. PubMed ID: 35175446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent facial and trigeminal nerve palsies in a child following COVID-19 vaccination with the Pfizer vaccine.
    Moezinia C; Harbinson EB; Maweni RM
    BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36717162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New-onset dermatomyositis following COVID-19: A case report.
    Shimizu H; Matsumoto H; Sasajima T; Suzuki T; Okubo Y; Fujita Y; Temmoku J; Yoshida S; Asano T; Ohira H; Ejiri Y; Migita K
    Front Immunol; 2022; 13():1002329. PubMed ID: 36353621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications.
    Heshin-Bekenstein M; Ziv A; Toplak N; Hagin D; Kadishevich D; Butbul YA; Saiag E; Kaufman A; Shefer G; Sharon O; Pel S; Elkayam O; Uziel Y
    Rheumatology (Oxford); 2022 Nov; 61(11):4263-4272. PubMed ID: 35179569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report.
    Morita S; Tsuji T; Kishimoto S; Uraki S; Takeshima K; Iwakura H; Furuta H; Nishi M; Inaba H; Matsuoka TA
    BMC Endocr Disord; 2022 Jul; 22(1):185. PubMed ID: 35854260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement.
    Kim Y; Kang J; Lee SG; Kim GT
    Z Rheumatol; 2022 Aug; 81(6):509-512. PubMed ID: 35587834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute Perimyocarditis in an Adolescent Japanese Male after a Booster Dose of the BNT162b2 COVID-19 Vaccine.
    Morita Y; Matsubara D; Seki M; Tamura D; Tajima T
    Tohoku J Exp Med; 2022 Oct; 258(3):177-182. PubMed ID: 36002252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience.
    Sánchez-Zapardiel E; Alós M; Nozal P; González-Muñoz M; Frauca-Remacha E; Gavilán LB; Quiles MJ; Hierro L; López-Granados E
    Front Immunol; 2022; 13():1049188. PubMed ID: 36505469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
    Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
    JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
    Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
    BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
    Partenope C; Pedranzini Q; Petri A; Rabbone I; Prodam F; Bellone S
    Front Endocrinol (Lausanne); 2023; 14():1166953. PubMed ID: 37143723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.
    Naim MY; Reed AM
    J Rheumatol; 2006 Jul; 33(7):1392-4. PubMed ID: 16821273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech.
    Suzuki M; Sekiguchi Y; Sasaki M; Inaba S; Oyama S; Inoue Y; Warabi M; Ohashi K; Inoshita S
    Intern Med; 2022; 61(19):2925-2929. PubMed ID: 36184535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vulvar Aphthous Ulcer in an Adolescent After Pfizer-BioNTech (BNT162b2) COVID-19 Vaccination.
    Wojcicki AV; O'Flynn O'Brien KL
    J Pediatr Adolesc Gynecol; 2022 Apr; 35(2):167-170. PubMed ID: 34706274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute-onset dacryoadenitis following immunisation with mRNA COVID-19 vaccine.
    Murphy T; Raheem Abu Shanab A; Kang K; Lyons CJ
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35256374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.